On Tuesday, Tenaya Therapeutics Inc (NASDAQ: TNYA) opened lower -0.69% from the last session, before settling in for the closing price of $0.86. Price fluctuations for TNYA have ranged from $0.36 to $4.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -15.48% over the past five years. Company’s average yearly earnings per share was noted 38.24% at the time writing. With a float of $134.18 million, this company’s outstanding shares have now reached $162.66 million.
Let’s look at the performance matrix of the company that is accounted for 97 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Tenaya Therapeutics Inc (TNYA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tenaya Therapeutics Inc is 17.51%, while institutional ownership is 27.56%. The most recent insider transaction that took place on May 16 ’25, was worth 615. In this transaction SVP, Finance of this company sold 1,390 shares at a rate of $0.44, taking the stock ownership to the 98,300 shares. Before that another transaction happened on May 16 ’25, when Company’s Chief Medical Officer sold 2,937 for $0.44, making the entire transaction worth $1,300. This insider now owns 171,856 shares in total.
Tenaya Therapeutics Inc (TNYA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 38.24% per share during the next fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Check out the current performance indicators for Tenaya Therapeutics Inc (TNYA). In the past quarter, the stock posted a quick ratio of 6.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.16, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Tenaya Therapeutics Inc (NASDAQ: TNYA) saw its 5-day average volume 3.34 million, a positive change from its year-to-date volume of 2.85 million. As of the previous 9 days, the stock’s Stochastic %D was 73.03%.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 70.10%, which indicates a significant decrease from 73.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0650 in the past 14 days, which was higher than the 0.0596 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5850, while its 200-day Moving Average is $1.2150. Nevertheless, the first resistance level for the watch stands at $0.8770 in the near term. At $0.9033, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.9467. If the price goes on to break the first support level at $0.8073, it is likely to go to the next support level at $0.7639. The third support level lies at $0.7376 if the price breaches the second support level.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
There are currently 162,667K shares outstanding in the company with a market cap of 138.38 million. Presently, the company’s annual sales total 0 K according to its annual income of -111,130 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -26,860 K.
